Objective: To analyse the literature on the treatment of adolescent painful endometriosis.
Method: This work is based on a Review of the literature between January 2006 and December 2017. The Medline (Pubmed) and Cochrane database were searched for meta-analyzes, randomized trials, literature reviews, controlled, not controlled and retrospective studies published on the subject. Studies concerning adolescent's dysmenorrhea without endometriosis were excluded.
Results: Study quality is heterogeneous. Dienogest and GnRH agonists (GnRHa) are the only treatments specifically evaluated for the treatment of adolescent endometriosis. They reduce the pain associated with endometriosis. Combined oral contraceptives have not been studied in the context of endometriosis but they are effective on dysmenorrhea. Add back therapy, containing estrogens improves bone mineral density and quality of life for young women treated with GnRHa.
Conclusion: Medical treatment of endometriosis in adolescent is associated with risks related to the young age. The therapeutic strategy should take into account the adverse effects of each treatment.
Keywords: Add-back therapy; Add-back thérapie; Adolescent; Adolescente; Bone mineral density; Densité minérale osseuse; Endometriosis; Endométriose; Hormonal treatment; Traitement hormonal.
Copyright © 2018 Elsevier Masson SAS. All rights reserved.